$18.02
0.08% yesterday
Nasdaq, Dec 30, 09:47 pm CET
ISIN
US2274831047
Symbol
CCRN

Cross Country Healthcare, Inc. Target price 2024 - Analyst rating & recommendation

Cross Country Healthcare, Inc. Classifications & Recommendation:

Hold
100%

Cross Country Healthcare, Inc. Price Target

Target Price $17.57
Price $18.06
Deviation
Number of Estimates 5
5 Analysts have issued a price target Cross Country Healthcare, Inc. 2025 . The average Cross Country Healthcare, Inc. target price is $17.57. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 0 Analysts recommend Cross Country Healthcare, Inc. to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cross Country Healthcare, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Cross Country Healthcare, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 2.02 1.34
28.04% 33.64%
EBITDA Margin 6.71% 3.85%
36.35% 42.60%
Net Margin 3.31% -0.50%
43.25% 115.12%

8 Analysts have issued a sales forecast Cross Country Healthcare, Inc. 2024 . The average Cross Country Healthcare, Inc. sales estimate is

$1.3b
Unlock
. This is
7.45% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.3b 7.33%
Unlock
, the lowest is
$1.3b 7.53%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.0b 28.04%
2024
$1.3b 33.64%
Unlock
2025
$1.3b 6.48%
Unlock
2026
$1.3b 3.20%
Unlock

8 Analysts have issued an Cross Country Healthcare, Inc. EBITDA forecast 2024. The average Cross Country Healthcare, Inc. EBITDA estimate is

$51.7m
Unlock
. This is
63.73% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$51.9m 64.50%
Unlock
, the lowest is
$50.8m 60.94%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $135m 54.19%
2024
$51.7m 61.87%
Unlock
2025
$50.8m 1.72%
Unlock
2026
$56.9m 12.09%
Unlock

EBITDA Margin

2023 6.71% 36.35%
2024
3.85% 42.60%
Unlock
2025
4.05% 5.19%
Unlock
2026
4.40% 8.64%
Unlock

6 Cross Country Healthcare, Inc. Analysts have issued a net profit forecast 2024. The average Cross Country Healthcare, Inc. net profit estimate is

$-6.8m
Unlock
. This is
245.92% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-6.4m 225.96%
Unlock
, the lowest is
$-7.5m 283.28%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $66.8m 59.16%
2024
$-6.8m 110.12%
Unlock
2025
$18.0m 366.57%
Unlock
2026
$22.0m 22.20%
Unlock

Net Margin

2023 3.31% 43.25%
2024
-0.50% 115.12%
Unlock
2025
1.44% 388.00%
Unlock
2026
1.70% 18.06%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 2.05 -0.21
59.16% 110.24%
P/E negative
EV/Sales 0.39

6 Analysts have issued a Cross Country Healthcare, Inc. forecast for earnings per share. The average Cross Country Healthcare, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.21
Unlock
. This is
250.00% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.20 233.33%
Unlock
, the lowest is
$-0.23 283.33%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $2.05 59.16%
2024
$-0.21 110.24%
Unlock
2025
$0.55 361.90%
Unlock
2026
$0.68 23.64%
Unlock

P/E ratio

Current -316.34 4,049.31%
2024
-86.71 72.59%
Unlock
2025
32.54 137.53%
Unlock
2026
26.63 18.16%
Unlock

Based on analysts' sales estimates for 2024, the Cross Country Healthcare, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.36 2.86%
2024
0.39 8.06%
Unlock
2025
0.42 6.94%
Unlock
2026
0.40 3.10%
Unlock

P/S ratio

Current 0.40 12.76%
2024
0.43 8.05%
Unlock
2025
0.46 6.92%
Unlock
2026
0.45 3.09%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today